Videos

Sabroxy® is a clinically studied nootropic supporting brain health

Company Logo

Released By Sabinsa Corporation

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In a 12-week randomized, double-blind, placebo-controlled trial, supplementation with 500 mg of Sabroxy® twice daily in older adults with self-reported memory complaints was associated with greater improvements in episodic memory and several computer-based cognitive tasks compared to the placebo.

      LEARN MORE >> 

      Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

      Request more information from Sabinsa Corporation